| Results summary | View all lists in L2L MDB | View all genes in G01A.profile.ud50 |
|
Reduced expression in XPC-defective fibroblasts, compared to normal fibroblasts, following treatment with cisplatin enrichment: 3.34-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 209294_X_AT | TNFRSF10B | G | S | tumor necrosis factor receptor superfamily, member 10b | |||||||||
| 202284_S_AT | CDKN1A | G | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | ||||||||||
| 212501_AT | CEBPB | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), beta | ||||||
| 203725_AT | GADD45A | G | X | growth arrest and DNA-damage-inducible, alpha | |||||||||
| 206026_S_AT | TNFAIP6 | X | C | S | tumor necrosis factor, alpha-induced protein 6 | ||||||||
| 205128_X_AT | PTGS1 | E | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | ||||||||||